البلد: أرمينيا
اللغة: الإنجليزية
المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
betamethasone (betamethasone 17-valerate)
Schering-Plough Labo N.V.
betamethasone (betamethasone 17-valerate)
1mg/g
ointment
Prescription
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CELESTODERM-V ® 2. COMPOSITION _active substance: _ betamethasone; 1 g of ointment contains betamethasone 17-valerate, equivalent to 1 mg betamethasone; _excipients: _ paraffin liquid, paraffin soft white. 3. PHARMACEUTICAL FORM Ointment. _BASIC PHYSICAL AND CHEMICAL PROPERTIES:_ Soft white smooth ointment without foreign matters. 4.1 THERAPEUTIC INDICATIONS Relief of the inflammatory manifestations of corticosteroid-responsive dermatoses such as: eczema (atopic, infantile, nummular), contact dermatitis, seborrheic dermatitis, neurodermatitis, solar dermatitis, exfoliative dermatitis, dermatitis due to radiation, intertrigo, psoriasis (excluding disseminated psoriasis). 4.2. DOSAGE AND ADMINISTRATION A thin film of Celestoderm-V should be applied to the affected area one to three times daily depending on severity of the condition. Application once or twice a day is often feasible and effective. Frequency of application should be determined according to severity of the condition. While mild cases may respond to once a day application, more severe cases may require more frequent application. Do not apply under occlusive dressings as it can potentiate adverse actions of medication. Continuous use of the medication should not exceed 4 weeks. After therapeutic effect is achieved frequency of Celestoderm-V should be decreased or less active topical corticosteroid should be used and supportive therapy should be continued with gradual withdrawal of the medication. If clinical improvement is not achieved by two to four weeks, examination should be repeated and treatment should be reviewed. 4.3 CONTRAINDICATIONS Bacterial infections of the skin (e.g. pyogenic dermatitis, tuberculosis and syphilitic processes), viral infections of the skin (e.g. varicella, herpes simplex, herpes zoster, verrucas vulga, warts, molluscum contagiosum), fungal infections of the skin, disseminated psoriasis, parasitic infections (e.g. itch), ulcerative skin lesions, wounds. Cor اقرأ الوثيقة كاملة